Companies: 10,795·Total market cap: $144.5T
Wave Life Sciences Ltd.

Wave Life Sciences Ltd.

WVENASDAQHealthcare● Active
$5.73
$-0.36(-5.91%)
Market Cap$1.1B
P/E Ratio—
52W High$21.73
52W Low$5.02
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Wave Life Sciences Ltd. (WVE) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001631574 · WVE · NASDAQ · as of Jun 8, 2026

Filing snapshot

695
Total Filings
8-K
Latest Form
2026-05-18
Most Recent
2015
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001631574 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-04-30
Fiscal Year End
Apr 30, 2026
Accession No.
0001193125-26-197330
Primary Document
wve-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001631574 · Accession 0001193125-26-197330

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
8-K
2026-05-18Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-05-18
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-13
View
DEF 14AProxy Statement
DEF 14A
2026-05-07
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-06
View
PRER14APRER14A
PRER14A
2026-05-01
View
10-K/AAnnual Report (Amended)
10-K/A
2026-04-30
View
10-QQuarterly Report
10-Q
2026-04-28
View
8-KCurrent Report
8-K
2026-04-28
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-21
View
8-KCurrent Report
8-K
2026-04-21
View
3Initial Statement of Beneficial Ownership
3
2026-04-17
View
3Initial Statement of Beneficial Ownership
3
2026-04-17
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-17
View
PRE 14APRE 14A
PRE 14A
2026-04-15
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-15
View
Showing 1–15 of 430 filingsForm 4 / 144 hidden· 695 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001631574  |  Exchange: NASDAQ · Healthcare

Wave Life Sciences Ltd. (NASDAQ: WVE) has submitted 695 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001631574, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Wave Life Sciences Ltd.'s most comprehensive regulatory disclosure. The most recent Wave Life Sciences Ltd. 10-K was filed on 2026-04-30 for fiscal year ending 2026. Historical WVE 10-K annual reports are available from 2015 through 2026.

Investors researching Wave Life Sciences Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
TERN SEC Filings →SYRE SEC Filings →ELVN SEC Filings →NTLA SEC Filings →TRML SEC Filings →AMLX SEC Filings →PGEN SEC Filings →ZBIO SEC Filings →
→ WVE Financials→ WVE Earnings→ WVE Insider Trades

Frequently Asked Questions

WVE SEC Filings · 8 questions

Wave Life Sciences Ltd. (WVE) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 695 filings and access original documents at no cost. Wave Life Sciences Ltd.'s CIK is 0001631574.

WVE SEC filingsWave Life Sciences Ltd. SEC documentsfind WVE 10-K